Web Results

www.pacermonitor.com/public/case/22348367/Adams,_et_al_v_Bayer_Corp,_et_al

Aug 28, 2017 ... Adams, et al v. Bayer Corp., et al (3:17-cv-04985), California Northern District Court, Filed: 08/28/2017 - PacerMonitor Mobile Federal and ...

www2.ca3.uscourts.gov/opinarch/122621p.pdf

Aug 21, 2013 ... Gabriel Carrera brings this class action against Bayer. Corporation and Bayer ... insufficient to prevent class certification. Carrera v. Bayer. Corp., Civ. A. No. 08- 4716, 2011 WL ..... 501.201 et seq. “[A] consumer claim for ...

www.nature.com/onc/journal/v19/n56/full/1204097a.html

Bayer and Agouron have discontinued their ongoing Phase III drug trials of ... Since MMPs also play an important role in tumor angiogenesis (Fang et al., ... et al., 1998; Nelson et al., 2000; Parsons et al., 1997; Wojtowicz-Praga et al., 1997). ..... was developed by Bayer Corporation with selective for MMP-2, MMP-9, MMP- 11, ...

link.springer.com/article/10.1007/s11664-016-5062-8

A. Colder, P. Marie, T. Wojtowicz, P. Ruterana, S. Eimer, L. Méchin, K. Lorenz, U. Wahl, E. Alves, and V. Matias et al., Superlattices Microstruct. 36, 713 .... J.L. Da Silva, M.V. Ganduglia-Pirovano, J. Sauer, V. Bayer, and G. Kresse, Phys. Rev. B 75, 045121 ... 2016 Springer International Publishing AG. Part of Springer Nature .